Glenmark Pharmaceuticals And Hikma Sign Exclusive Licensing Agreement
HIGHLIGHTS Glenmark Specialty S.A and Hikma Pharmaceuticals PLC have signed an agreement to commercialize Ryaltris™. Ryaltris™ can treat the symptoms associated with seasonal allergic rhinitis. Research-led global integrated pharmaceutical company Glenmark Pharmaceuticals Ltd. has announced that its Swiss subsidiary, Glenmark…
